GlassScriptPhysician profile
Richard T Shimer
NPI 1508832924
$13,609.38
in general payments reported to CMS, 2019-2025
20 companies · $74.88 in 2025
The $74.88 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $688 · 2021: $174 · 2022: $6,145 · 2023: $5,811 · 2024: $545 · 2025: $74.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,267 · Food and Beverage: $1,143 · Gift: $21.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,266.82 |
| Food and Beverage | $1,143.10 |
| Gift | $21.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,048.05 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $687.95 | 2020 | |
| Zimmer Biomet Holdings, INC. | $442.95 | 2023 | Advantagerib, Ribfix Blu Advantage |
| Ethicon US, LLC | $414.05 | 2022-2025 | Enseal, Echelon; Endopath, Echelon Flex |
| Kerecis Limited | $360.20 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Prytime Medical Devices, INC. | $145.56 | 2019 | |
| Integra Lifesciences Corporation | $144.69 | 2021 | |
| Novo Nordisk INC | $77.17 | 2023-2024 | Wegovy |
| Tela Bio, INC. | $48.65 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbott Laboratories | $33.03 | 2023 | Freestyle Libre 3 |
| Innocoll Pharmaceuticals Limited | $30.65 | 2022 | |
| Davol INC. | $28.87 | 2021 | |
| Acell, INC. | $25.89 | 2019 | |
| Haemonetics Corporation | $21.93 | 2023 | |
| Kci USA, INC. | $20.80 | 2023 | V.A.C. Veraflo, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17.74 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.42 | 2023 | Trintellix |
| Medtronic, INC. | $15.98 | 2022 | |
| Merck Sharp & Dohme LLC | $14.98 | 2023 | Verquvo, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.82 | 2023 | Trulance, Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Shimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.